Alzchem Group für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2YNT3 / ISIN: DE000A2YNT30

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Orderbuch	Analysen
Historisch

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Orderbuch
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Alzchem Group AG

30.10.25		EQS-News: Erfolgreiche Neunmonatsbilanz 2025: Alzchem Group AG steigert EBITDA um 12 % und bestätigt Prognose für Rekordjahr 2025 (EQS Group)
30.10.25		EQS-News: Successful nine-month results for 2025: Alzchem Group AG increases EBITDA by 12% and confirms forecast for record year in 2025 (EQS Group)
20.10.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
20.10.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
15.10.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
13.10.25		Alzchem Group AG und Ehrmann starten Kooperation: Neue High Protein Creatine Produkte mit Creavitalis® ab Oktober im Handel (EQS Group)
13.10.25		Alzchem Group AG and Ehrmann launch cooperation: New high-protein creatine products with Creavitalis® available in stores from October (EQS Group)
09.10.25		Alzchem Group AG remains in the game: Creapure® and FC Bayern Basketball continue their collaboration in the upcoming season (EQS Group)
09.10.25		Alzchem Group AG bleibt im Spiel: Creapure® und FC Bayern Basketball setzen ihre Zusammenarbeit in der kommenden Saison fort (EQS Group)
12.09.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
05.09.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
02.09.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.07.25		EQS-News: Alzchem Group AG continues growth trajectory in the first half of 2025 – forecast for the full year confirmed (EQS Group)
30.07.25		EQS-News: Alzchem Group AG setzt Wachstumskurs im 1. Halbjahr 2025 fort – Prognose für Gesamtjahr bekräftigt (EQS Group)
23.07.25		EQS-AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] (EQS Group)
23.07.25		EQS-AFR: Alzchem Group AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG (EQS Group)
11.07.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
10.07.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
07.07.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
07.07.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
07.07.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
24.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
24.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
24.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
23.06.25		EQS-News: Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 - 11. Zwischenmeldung (EQS Group)
23.06.25		EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 11th interim report (EQS Group)
20.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
20.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
20.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
18.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
18.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
18.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
16.06.25		EQS-News: Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 - 10. Zwischenmeldung (EQS Group)
16.06.25		EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 10th interim report (EQS Group)
10.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
06.06.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
23.05.25		EQS-PVR: Alzchem Group AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
23.05.25		EQS-DD: Alzchem Group AG: four two na GmbH, sell (EQS Group)
23.05.25		EQS-DD: Alzchem Group AG: four two na GmbH, Verkauf (EQS Group)
23.05.25		EQS-News: Alzchem Group AG mit erfolgreichem Abschluss der langfristigen Nachfolgeplanung im Vorstand: Aufsichtsrat beruft Dr. Jürgen Sans zum 1. Januar 2026 als Chief Operating Officer (EQS Group)
13.05.25		EQS-DD: Alzchem Group AG: Andreas Lösler, Kauf (EQS Group)
09.05.25		EQS-News: Alzchem Group AG: Hauptversammlung stimmt Dividendenerhöhung um 50 % auf 1,80 Euro und Wiederwahl der Aufsichtsratsmitglieder zu (EQS Group)
09.05.25		EQS-News: Alzchem Group AG: Annual General Meeting approves 50% dividend increase to EUR 1.80 and re-election of Supervisory Board members (EQS Group)
30.04.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.04.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.04.25		EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.04.25		EQS-News: Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched (EQS Group)

1 | Weiter

Newssuche

Alzchem Group Peer Group Nachrichten

30.10.25		AlzChem-Aktie stark gesucht: Spezialchemie beflügelt Gewinne
30.07.25		Alzchem-Aktie bricht dennoch ein: Spezialchemie zahlt sich aus - Alzchem mit Umsatz- und Gewinnplus
09.05.25		SDAX-Wert Alzchem Group-Aktie: Über diese Dividende können sich Alzchem Group-Aktionäre freuen
30.04.25		Alzchem-Aktie trotzdem auf Verkaufszetteln: Alzchem steigert Gewinn
04.04.25		Schwacher Wochentag in Frankfurt: SDAX notiert zum Start des Freitagshandels im Minus
03.04.25		Donnerstagshandel in Frankfurt: SDAX zum Handelsende in der Verlustzone
03.04.25		Börse Frankfurt in Rot: SDAX gibt nach
03.04.25		Zurückhaltung in Frankfurt: SDAX verliert am Mittag

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	02.11.2025 12:00
Kaufwert:	EUR
	Hinzufügen Speichern

Alzchem Group Aktie

WKN DE: A2YNT3 / ISIN: DE000A2YNT30

Nachrichten zu Alzchem Group AG

Newssuche

Alzchem Group Peer Group Nachrichten

Meistgelesene Nachrichten